Mabpharm Limited (HK:2181) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Mabpharm Limited successfully held its Annual General Meeting (AGM) on June 21, 2024, where all proposed resolutions were unanimously passed by shareholders. Key outcomes included the re-election of executive and non-executive directors, re-appointment of Ernst & Young as auditors, and approval for the board to repurchase and issue additional shares. The total number of shares voted was 3,568,927,860, representing a 100% approval rate with no opposing votes.
For further insights into HK:2181 stock, check out TipRanks’ Stock Analysis page.